Search research articles
Contact Us
Filters
Showing results (181-190 of 439) with videos related to
Page
of 44
Sort By:
Breast Cancer Research and Treatment
|
July 27, 2007
Inflammatory breast cancer: PET/CT, MRI, mammography, and sonography findings
Wei T Yang, Huong T Le-Petross, Homer Macapinlac, et al.
JAMA Network Open
|
January 22, 2024
Concurrent Tissue and Circulating Tumor DNA Molecular Profiling to Detect Guideline-Based Targeted Mutations in a Multicancer Cohort
Wade T Iams, Matthew Mackay, Rotem Ben-Shachar, et al.
Breast (Edinburgh, Scotland)
|
August 11, 2016
Clinical-pathological features and treatment modalities associated with recurrence in DCIS and micro-invasive carcinoma: Who to treat more and who to treat less
Angela Toss, Juan Palazzo, Adam Berger, et al.
European Urology
|
December 26, 2017
Efficacy Against Human Prostate Cancer by Prostate-specific Membrane Antigen-specific, Transforming Growth Factor-β Insensitive Genetically Targeted CD8<sup>+</sup> T-cells Derived from Patients with Metastatic Castrate-resistant Disease
Qiang Zhang, Brian T Helfand, Benedito A Carneiro, et al.
Molecular Cancer Therapeutics
|
April 28, 2017
Concordance of Genomic Alterations by Next-Generation Sequencing in Tumor Tissue versus Circulating Tumor DNA in Breast Cancer
Young Kwang Chae, Andrew A Davis, Sarika Jain, et al.
Breast Cancer Research and Treatment
|
November 11, 2009
GPR30 and estrogen receptor expression: new insights into hormone dependence of inflammatory breast cancer
Hugo Arias-Pulido, Melanie Royce, Yun Gong, et al.
Ebiomedicine
|
February 13, 2016
Arterial Blood, Rather Than Venous Blood, is a Better Source for Circulating Melanoma Cells
Mizue Terai, Zhaomei Mu, David J Eschelman, et al.
Breast Cancer Research : BCR
|
May 5, 2016
Mitosis in circulating tumor cells stratifies highly aggressive breast carcinomas
Daniel L Adams, Diane K Adams, Steingrimur Stefansson, et al.
Anticancer Research
|
April 7, 2019
Circulating Tumor Cells With Epithelial-to-mesenchymal Transition Phenotypes Associated With Inferior Outcomes in Primary Breast Cancer
Michal Mego, Marian Karaba, Gabriel Minarik, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
November 5, 2014
PARP inhibitors for chemoprevention--letter
Saswati N Chand, Fernando F Blanco, Masaya Jimbo, et al.
Page
of 44
Search research articles
Search
Showing results (181-190 of 439) with videos related to
Sort By:
Page
of 44
Breast Cancer Research and Treatment
|
July 27, 2007
Inflammatory breast cancer: PET/CT, MRI, mammography, and sonography findings
Wei T Yang, Huong T Le-Petross, Homer Macapinlac, et al.
JAMA Network Open
|
January 22, 2024
Concurrent Tissue and Circulating Tumor DNA Molecular Profiling to Detect Guideline-Based Targeted Mutations in a Multicancer Cohort
Wade T Iams, Matthew Mackay, Rotem Ben-Shachar, et al.
Breast (Edinburgh, Scotland)
|
August 11, 2016
Clinical-pathological features and treatment modalities associated with recurrence in DCIS and micro-invasive carcinoma: Who to treat more and who to treat less
Angela Toss, Juan Palazzo, Adam Berger, et al.
European Urology
|
December 26, 2017
Efficacy Against Human Prostate Cancer by Prostate-specific Membrane Antigen-specific, Transforming Growth Factor-β Insensitive Genetically Targeted CD8<sup>+</sup> T-cells Derived from Patients with Metastatic Castrate-resistant Disease
Qiang Zhang, Brian T Helfand, Benedito A Carneiro, et al.
Molecular Cancer Therapeutics
|
April 28, 2017
Concordance of Genomic Alterations by Next-Generation Sequencing in Tumor Tissue versus Circulating Tumor DNA in Breast Cancer
Young Kwang Chae, Andrew A Davis, Sarika Jain, et al.
Breast Cancer Research and Treatment
|
November 11, 2009
GPR30 and estrogen receptor expression: new insights into hormone dependence of inflammatory breast cancer
Hugo Arias-Pulido, Melanie Royce, Yun Gong, et al.
Ebiomedicine
|
February 13, 2016
Arterial Blood, Rather Than Venous Blood, is a Better Source for Circulating Melanoma Cells
Mizue Terai, Zhaomei Mu, David J Eschelman, et al.
Breast Cancer Research : BCR
|
May 5, 2016
Mitosis in circulating tumor cells stratifies highly aggressive breast carcinomas
Daniel L Adams, Diane K Adams, Steingrimur Stefansson, et al.
Anticancer Research
|
April 7, 2019
Circulating Tumor Cells With Epithelial-to-mesenchymal Transition Phenotypes Associated With Inferior Outcomes in Primary Breast Cancer
Michal Mego, Marian Karaba, Gabriel Minarik, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
November 5, 2014
PARP inhibitors for chemoprevention--letter
Saswati N Chand, Fernando F Blanco, Masaya Jimbo, et al.
Page
of 44